论文部分内容阅读
目的探讨盐酸替罗非班联合低分子肝素治疗急性下肢深静脉血栓形成的效果。方法选择2015年3月至2017年3月成都长济医院诊治的急性下肢深静脉血栓形成患者80例,根据治疗方式,将患者分为对照组和观察组。对照组患者单纯应用低分子肝素治疗,观察组患者应用盐酸替罗非班+低分子肝素治疗。比较2组患者的各项研究数据。结果观察组患者的临床治疗效果优于对照组,组间比较,差异有统计学意义(P<0.05)。结论用盐酸替罗非班+低分子肝素治疗急性下肢深静脉血栓形成患者的临床效果明显,可以充分改善患者各项临床症状,值得临床推广应用。
Objective To investigate the effect of tirofiban hydrochloride combined with low molecular weight heparin in the treatment of acute deep venous thrombosis of the lower extremities. Methods Eighty patients with acute DVT from March 2015 to March 2017 in Chengdu Changji Hospital were divided into control group and observation group according to the treatment method. Patients in the control group were treated with low molecular weight heparin alone. Patients in the observation group were treated with tirofiban hydrochloride and low molecular weight heparin. The data of two groups of patients were compared. Results The clinical efficacy of the observation group was better than that of the control group. There was significant difference between the two groups (P <0.05). Conclusion The clinical effect of tirofiban plus low molecular weight heparin in the treatment of patients with acute lower extremity deep venous thrombosis is obvious. It can fully improve the clinical symptoms of patients and is worthy of clinical application.